Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Hims & Hers Health, Inc.

NYSE: HIMS · Industrial Applications and Services · 10 alerts · CIK 1773751

Share price
$18.56Close, Nov 16
Sector
Industrial Applications and Services
Industry
Services-Offices & Clinics of Doctors of MedicineSIC 8011

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Hims & Hers Health, Inc. filings on SEC EDGAR ↗

4:18 PM ET 10-Q
Financial Results ▶ Call

Hims & Hers Health Q3 2026 Results: Net Loss of $33M

Hims & Hers Health, Inc. reported a net loss of $33.0 million for the third quarter of 2026, a significant decline from a net income of $15.8 million in the prior year period, despite revenue growing to $890.4 million. The company's balance sheet shows a substantial increase in goodwill and intangible assets, reflecting significant acquisition activity during the first nine months of the year.

Key figure
Net loss $33M
4:13 PM ET 8-K
Leadership Change

Hims & Hers Health Leadership Change

Hims & Hers Health, Inc. increased its board size to ten and appointed Dr. Andrew Huberman as a director, effective November 4, 2026. Alongside his board role, Dr. Huberman entered into a brand marketing and advisory agreement worth $3.5 million annually, while his media company, Scicomm Media LLC, secured a $5 million annual podcast advertising contract.

Counterparty
Dr. Andrew Huberman
Term
through 2027 annual meeting
4:12 PM ET 8-K
Financial Results

Hims & Hers Health Financial Results

Hims & Hers Health reported Q3 2026 revenue of $890.4 million, a 49% year-over-year increase driven by significant international growth and a 13% rise in subscribers to 2.8 million. The company reported a net loss of $33.0 million compared to a profit in the prior year, while tightening its full-year revenue guidance and reducing its Adjusted EBITDA outlook.

Term
Q3 2026

“In healthcare, whoever owns the customer relationship wins, and that’s exactly what we’re building toward at Hims & Hers. Today, customers want real choice, real value, and a care team that knows them.”

Andrew Dudum, co-founder and CEO

“In the third quarter, we continued to apply what we’ve learned to make deliberate strategic decisions to position Hims & Hers for durable, multi-year growth.”

Yemi Okupe, Chief Financial Officer
4:12 PM ET Form 4
Insider Selling

Hims & Hers Health CLO Soleil Boughton Sells $95.6K of Stock

Soleil Boughton, CLO, sold 3,462 shares of Hims & Hers Health, Inc. at $27.60 a share, worth $95.6K in total on Oct 28, 2026. Shares held after the trade: 293,886 (-1.2%).

Value
$95.6K
Shares
3,462
Price
$27.60
Role
CLO
Holding change
-1.2%
Trade date
Oct 28, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.